Medical/Pharmaceuticals
BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program
* Encouraging non-human primate (NHP) findings support the progression of IV-formulatedBMD-001 ahead of formal clinical studies for Alzheimer's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease * Further validation of Brain Targeting RNAi Nanomedicine (BTRiNTM), including target...
2023-04-24 20:00
1399
DetectedX Launches MyImageDx Online Learning Platform for Radiology Educators at Association of University Radiologists and Society of Breast Imaging Meetings
Fully Customizable Interactive Learning Platform Enables Educators to Deliver Image-Based Learning using DetectedX's Award-Winning Online Training Technology and Tools SYDNEY, April 24, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today...
2023-04-24 20:00
1633
WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022
Revenue Up 5.8% Year-Over-Year to RMB8,964 Million Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 Million Diluted Earnings per Share (EPS) Up 35.8% Year-Over-Year to RMB0.72 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 14.1% Year-Over-...
2023-04-24 18:03
2376
Tibetan medicine advanced over past decade
BEIJING, April 24, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: Adhering to an equal emphasis on traditional Chinese and Western medicine, the government of the Tibet autonomous region has increased financial investment, formulated supportive policies and promoted the development of...
2023-04-24 17:04
1389
Samsung Biologics Reports First Quarter 2023 Financial Results
* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. * Expected to maintain a strong growth trajectory with the full utilization of existing and newly expanded capacities. INCHEON, South Korea, April 24, 2023 /PRNews...
2023-04-24 14:51
2277
Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions
HANGZHOU, China, April 23, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. ("Hicicare"). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and ...
2023-04-24 10:36
1931
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI
* The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed * The latest preclinical data explored the antitumor efficacy and the intracranial activity of BBT-207 SEONGNAM, South Korea and CAMBRIDGE, Mass., April 23, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ...
2023-04-24 10:00
1650
Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform
LONDON, April 23, 2023 /PRNewswire/ -- On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical o...
2023-04-24 08:00
2622
ITRI Took Home Three Edison Awards(TM) in 2023
HSINCHU, April 21, 2023 /PRNewswire/ -- The highly-anticipated 2023 Edison
Awards™
2023-04-21 19:27
3147
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr.Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall c...
2023-04-21 09:06
2121
CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer
SHANGHAI, April 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that CT041, an autologous CAR T-cell product candidate against the p...
2023-04-20 20:50
2397
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics
* Implementation of Samyang Holdings' drug delivery technology for the development of mRNA-based cancer therapeutics SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement onThursday, April 20th, f...
2023-04-20 20:30
1776
CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA
Proceeds raised will be used to fund future acquisitions, and fuel business development of innovative pipeline assets SINGAPORE, April 20, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered inSingapore, and Hasten Biopharmaceutic Company Lim...
2023-04-20 13:00
2220
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 19, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-20 08:00
1940
500 women join Australia's landmark maternity medical device study
SYDNEY, April 19, 2023 /PRNewswire/ -- Medical device company Baymatob has successfully completed one ofAustralia's largest maternity health studies for a medical device, enrolling 500 mothers in a pilot study to evaluate its AI-guided labor monitoring device, Oli. The device is the only product ...
2023-04-19 21:08
2037
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
SUZHOU, China, April 19, 2023 /PRNewswire/ -- Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the "Drug Manufacturing License" (C Certificate) by the Jiangsu Medical Products...
2023-04-19 21:00
2112
Concord Medical Files 2022 Annual Report on Form 20-F
BEIJING, April 19, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extens...
2023-04-19 20:30
3088
Health In Tech to Showcase Cutting-Edge Benefits Solutions at the National Association of Benefits and Insurance Professionals (NABIP)-TX 2023 Conference as a Corporate Sponsor
Be sure to stop by booth #60 to learn more about Health In Tech's suite of offerings for individuals searching for more cost stability and clarity - particularly those facing difficulties due to Humana's departure from the self-funding space. STUART, Fla., April 19, 2023 /PRNewswire/ -- Health I...
2023-04-19 20:30
1828
China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering
HANGZHOU, China, April 19, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, announced today that the...
2023-04-19 20:30
2976
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use
- Subjects in Herniorrhaphy Study Dosed - Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed SAN DIEGO, April 18, 2023 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the re...
2023-04-19 11:05
1608
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7722
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7116